Daily Tadalafil in Diabetic ED Patients

ConditionErectile Dysfunction Associated With Type 2 Diabetes Mellitus

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age30-60

SponsorSouth Valley University

About this trial

This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Methyl Cellulose Placebo

Treatment groups

60 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

South Valley University

Lead sponsor

Source ClinicalTrials.gov